Wed, Sep 07, 2022
FDA said it has authorised bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines for use as a single booster dose at least two months after completing primary or booster vaccination.
More >
Thu, Sep 01, 2022
India completed new milestone of 200 crore covid-19 vaccination. Watch this video for more details.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
